QuantumScape stock jumps 10% as $2.9 billion valuation gap sharpens execution test

QuantumScape stock jumps 10% as $2.9 billion valuation gap sharpens execution test

NEW YORK, August 7, 2026, 17:06 EDT — U.S. markets closed.

  • QuantumScape Corporation closed at $6.08, up 9.8% on Friday.
  • Shares gained 16.5% from their July 31 closing price.
  • A simple valuation bridge leaves $2.89 billion above reported Q2 liquidity.

QuantumScape climbed into Friday’s close and finished near its session high. The gain lifted its weekly advance to 16.5%.

No new company news release accompanied the move. QuantumScape’s investor page showed July 22 as its latest release.

The rally spread across several listed battery developers, based on Friday’s closing data.

CompanyCloseFriday moveVolumeMarket value
QuantumScape Corporation $6.08+9.8%17.82 million$3.75 billion
SES AI Corporation $0.5621+10.6%25.00 million$187 million
Solid Power Inc. $2.33+6.6%3.35 million$527 million
Amprius Technologies Inc. $11.85+5.9%6.35 million$1.62 billion

That breadth suggests stronger sector risk appetite, rather than a QuantumScape-only catalyst. It also tempers the signal from one strong session.

The more useful investor test compares QuantumScape’s valuation with available liquidity. The market value reached about 4.4 times Q2 liquidity.

Valuation bridgeAmount
Market capitalization$3.75 billion
Reported Q2 liquidity$859 million
Market value divided by liquidity4.4 times
Market value less liquidity — calculated$2.89 billion

The last figure is a mechanical comparison, not enterprise value. It approximates equity value assigned beyond the company’s liquid resources.

Current revenue does not support that residual. QuantumScape remains development-stage and reports no revenue to date. Q2 customer billings were $10.8 million, but were not GAAP revenue.

Spending improved from the comparable quarter. Operating cash use also declined, though more slowly.

$ millionsQ2 2026Q2 2025Change
Operating expenses$106.1$123.6-14.1%
Net loss$98.2$114.7-14.4%
Operating cash used$56.7$61.8-8.2%

Lower spending moderated cash erosion. However, full-year adjusted EBITDA loss guidance remains $250 million to $275 million. Capital-spending guidance was lowered to $27 million to $37 million.

The Eagle Line now carries the main execution burden. Core tools exceeded 90% uptime during Q2. Management targets another doubling of cell output during the second half.

External validation broadened in June. Honda Motor Co. signed a multi-year research agreement. Honda R&D executive Atsushi Ogawa said, “QS technology demonstrated compelling and unique advantages during our evaluation.” QuantumScape

Research is not a production award. QuantumScape says its only commercialization-intent agreement remains with Volkswagen AG’s PowerCo unit.

The latest amendment made PowerCo funding smaller and more milestone-dependent.

PowerCo termJuly 2025 structureJuly 2026 amendmentEffect
Payment basisCost reimbursement, subject to goalsMilestones tied to cell delivery and validationMore direct milestone dependence
Maximum program paymentsUp to $130.7 million$75.4 million, including prior paymentsDown 42.3%
Stated payment windowTwo years from July 2025Two years from July 2026Reset under new milestones

The amendment reduces maximum program payments by $55.3 million. QuantumScape received $10.4 million during Q2 and recorded it as capital. No shares were issued for that payment.

Analyst recommendations remain cautious after Friday’s rebound. The current S&P Global Inc. poll contains no Buy ratings.

Firm or consensusRecommendationPrice targetLatest date
S&P Global consensus, nine analystsSeven Hold, two Strong Sell$6.66 averageCurrent snapshot
Evercore ISI / Evercore Inc. Hold$10.00July 28
TD Cowen / Toronto-Dominion Bank Hold$6.00, cut from $8.00July 24
HSBC Holdings plc Hold$8.30February 18

The average target sits only 9.5% above Friday’s close. Yet forecasts range from $2.50 to $10. That fourfold spread reflects deep disagreement over commercial execution.

QuantumScape’s public calendar showed no scheduled company event next week. July CPI arrives Wednesday, followed by PPI Thursday and retail sales Friday. Without company news, those releases could steer rate-sensitive growth shares.

Risks: Eagle Line delays, failed validation milestones or fresh fundraising could pressure the shares. Faster sample output and a completed PowerCo licence would strengthen the case.

TS2 TECH • EXTENDED COVERAGE

Further analysis

How much did the revised PowerCo agreement reduce available funding?
The PowerCo program funding ceiling fell 42%, from $130.7 million to $75.4 million. Neither figure represented guaranteed cash. The revised ceiling includes prior payments and depends on cell delivery and validation milestones. The separate $130 million initial royalty still requires technical milestones and license execution. This leaves less partner funding before commercial royalties can begin.
Is Eagle Line performance now strong enough to prove manufacturing scale?
Management reported core-tool uptime above 90% and productivity meeting internal targets. It aims to double cell output during the second half of 2026. However, QuantumScape disclosed no commercial yield, unit cost, or validated gigawatt-hour technology transfer. PowerCo’s delivery and validation milestones remain the strongest disclosed external test.
Is QuantumScape funded through its next commercial milestones?
QuantumScape ended June with $859.0 million in cash and marketable securities. First-half operating cash use was $116.3 million, while equipment purchases reached $14.6 million. Management kept 2026 adjusted EBITDA-loss guidance at $250 million to $275 million. It lowered capital-spending guidance to $27 million–$37 million. The filing supports at least twelve months of funding, not full commercialization.
Does Honda materially reduce QuantumScape’s reliance on PowerCo?
Honda signed a multi-year joint research agreement after completing a detailed technology evaluation. No production license, volume commitment, vehicle launch, or revenue contribution was disclosed. QuantumScape’s SEC filing still identifies PowerCo as its only commercialization-intent agreement. Honda improves external validation, but it does not yet secure production demand.
Did Friday’s 9.8% rally follow a new fundamental catalyst?
QS last traded at $6.08 on August 7, up 9.8% from Thursday. QuantumScape issued no company release or SEC filing after July 24. The rally therefore lacks a verified company-specific fundamental catalyst. Price action alone does not alter unresolved manufacturing and commercialization risks.
Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Stellantis shares dip with 1.8% margin as U.S. markets close and after-hours trading shows activity
Previous Story

Stellantis shares dip with 1.8% margin as U.S. markets close and after-hours trading shows activity

Westwater Resources soars 88%, gains roughly $46 million after securing U.S. graphite loan
Next Story

Westwater Resources soars 88%, gains roughly $46 million after securing U.S. graphite loan